Brief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
02/10/2026 23:06
BRIEF-Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya Oct 2 (Reuters) - Dr. Reddy's Laboratories Limited REDY.NS:
TONIX PHARMACEUTICALS: DR. REDDY'S FILES ANDA WITH PARAGRAPH IV PATENT CERTIFICATION FOR GENERIC TONMYA ON OCT 1 - SEC FILING
TONIX PHARMACEUTICALS: PARAGRAPH IV CERTIFICATION CHALLENGES FOUR TONMYA PATENTS LISTED IN FDA ORANGE BOOK - SEC FILING
TONIX PHARMACEUTICALS: CO INTENDS TO ENFORCE TONMYA INTELLECTUAL PROPERTY RIGHTS - SEC FILING
Source text: [ID:n0001493152-26-045603]
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview